Navigation Links
NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
Date:9/15/2008

PARIS, September 15 /PRNewswire-FirstCall/ -- NicOx S.A. (Euronext Paris: COX) today announced successful top-line results from the second phase 3 study for naproxcinod in 1020 patients with osteoarthritis of the knee (the 302 study). Both doses of naproxcinod (750 mg and 375 mg bid) met the three co-primary efficacy endpoints at week-13 (p<0.001). The study also comfortably met the main secondary endpoint, demonstrating that naproxcinod 750 mg bid was statistically non-inferior to naproxen 500 mg bid on the WOMAC(TM) pain and function subscales at week-13 and 26. Naproxcinod is the first compound in the new Cyclooxygenase-Inhibiting Nitric Oxide-Donator (CINOD) class of anti-inflammatory agents, which NicOx is developing as a drug for the treatment of the signs and symptoms of osteoarthritis.

NicOx' phase 3 clinical program for naproxcinod consists of three pivotal trials (including the previously completed 301 study in osteoarthritis of the knee and the ongoing 303 study in osteoarthritis of the hip, in addition to the 302 study). Overall, the results of the 302 study support naproxcinod's non-detrimental effect on blood pressure and are consistent with those observed in the 301 study, with naproxcinod 750 mg bid showing a numerical reduction in systolic and diastolic blood pressure at week-13 and 26, compared to baseline and naproxen 500 mg bid. Existing non-steroidal anti-inflammatory agents (NSAIDs) such as ibuprofen and naproxen have the tendency to raise blood pressure, which is a side effect of particular concern in the osteoarthritis population.

A post hoc pooled analysis of the blood pressure data from the 301 and 302 studies showed a statistically significant reduction for naproxcinod 750 mg bid, compared to naproxen 500 mg bid, in terms of the mean change from baseline at week-13, of 2.3 mmHg (p=0.004) for systolic blood pressure and 1.1 mmHg (p=0.034) for diastolic blood pressure. In the planning of the phase 3 program, NicOx had fo
'/>"/>

SOURCE NicOx
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension
2. NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients
3. NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR
4. NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
5. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
6. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
7. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
8. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
9. NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020
10. NicOx Naproxcinod Phase 3 Results Presented at American College of Rheumatology
11. NicOx Naproxcinod ABPM Data Presented at American Heart Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014  A Boston Scientific ... study on stent removability and preliminary long term ... published in the August issue of the peer-reviewed ... 1 is being conducted in 11 countries ... covered self-expanding metal stents (FCSEMS) after extended indwell ...
(Date:8/29/2014)...  BC Technical, the nation,s leading non-OEM provider of ... leader in sales, service and installation of GE MRI ... to continue to expand their resources and inventory while ... "We are committed to driving higher ... president and CEO of BC Technical. "We set out ...
(Date:8/29/2014)... , August 29, 2014 ... Seed Oil Market by Extraction type (SFE, Cold ... & Personal Care, Pharmaceutical, Food Supplements, Fragrance, & Others) ... by MarketsandMarkets, defines and segments the Amaranth Seed ... the market size in terms of value. The ...
Breaking Medicine Technology:Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4BC Technical Acquires Polaris Medical Imaging 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4
... Dec. 7 In addition to data released in ... the Company,s PROTECT-1 (the Prospective Randomized Oral Therapy Evaluation ... with moderate-to-severe Crohn,s disease. While the earlier announcement ... from the Maintenance period of the study showed that ...
... , WESTWOOD, Mass., Dec. 7 CompuCyte Corporation, ... and the leading supplier of laser scanning cytometers, announced ... of imaging cytometers to include four-laser versions of the ... four excitation lasers chosen from a palette of 405, ...
Cached Medicine Technology:ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7CompuCyte Announces the Release of Four-Laser Imaging Cytometers 2
(Date:8/29/2014)... famous online supplier of trendy clothes, has unveiled its new ... all these mini outfits are offered at discounted rates, up ... September 14. , The company’s senior spokesman states, “To ... designs, we have listed some of the best-selling items in ... to get high quality, fashionable clothes. Many of our sexy ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 DailyGossip.org publishes ... is an absolutely unique method of curing multiple sclerosis ... program was created by Dr. Gary M. Levin, who ... specialist started to become interested in alternative remedies for ... classical remedies cannot be effective in all cases for ...
(Date:8/29/2014)... Champion boxers Laila Ali and Victor Ortiz are ... annual MDA Show of Strength Telethon this Labor Day ... stations across the country. , Ali, former super ... with Laila Ali," will introduce a performance from American ... Association's nationally broadcast show. , Ortiz will introduce R&B ...
(Date:8/29/2014)... According to a CNN article, entitled Medical Marijuana ... study found that those states who legalized medical marijuana ... in the number of painkiller overdoses seen. By reviewing ... comparing various states with and without legalized medical marijuana, ... a 25% decrease in painkiller prescription overdoses in legalized ...
(Date:8/29/2014)... According to new research presented in a Science Daily article ... Drug Misuse Among Young Adults (8/16), peer pressure should ... it comes to prescription drug abuse. Researchers from Purdue University ... problem which influences misuse of prescription drugs is access to ... to have fun with other using friends. Evidently there is ...
Breaking Medicine News(10 mins):Health News:Cheap Sexy Mini Dresses Added To The Product Line Of Skmen.com 2Health News:New Natural Multiple Sclerosis Treatment Review Reveals Gary M. Levin’s Unique Cure 2Health News:Champion Boxers Fight Back Against Muscle Disease 2Health News:Champion Boxers Fight Back Against Muscle Disease 3Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 2Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 3Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 2Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 3
... MA Brandeis psychologist Margie E. Lachman has been awarded ... on Aging to learn more about factors that can ... research will identify modifiable beliefs and behaviors that are ... life. , Many middle-aged and older adults believe that ...
... Lives of Eight Families Living with Autism, NEW ... television premiere of Lauren Thierry,s documentary Autism Every Day,on ... Awareness Day by,the United Nations. The film, which debuted ... day in the lives of eight families,struggling to raise ...
... editors of the Proceedings of the National Academy of ... the 2007 Cozzarelli Prize, an award for papers that ... , The award was established in 2005 as the ... Cozzarelli Prize in 2007 to honor late PNAS Editor-in-Chief ...
... 13 Leading speech,pathologist and autism consultant Valerie ... needs technologies at the "Autism Through,the Lifespan" conference ... "The future is now for an entire generation ... of their lives and becoming young,adults with autism. ...
... Inc. (Pink Sheets: HCFE) has established HEALTHY COFFEE ... distribution of Healthy Coffee,drinks and wellness products through ... About Healthy Coffee USA, Inc., HEALTHY COFFEE ... Coffee by providing an opportunity for the average ...
... With Erectile Dysfunction Are Smokers, NEW YORK, Feb. ... attractiveness, it does the exact opposite when he reaches,the ... recent studies, 60-percent of all men who smoke suffer,from ... more passion. In an effort to dramatically improve upon ...
Cached Medicine News:Health News:Brandeis researcher awarded grant to investigate memory and aging 2Health News:Sundance Channel to Premiere Documentary Autism Every Day on World Autism Awareness Day, April 2nd at 8:00pm et/pt 2Health News:PNAS announces 2007 Cozzarelli Prize recipients 2Health News:A Sneak Peek Into the Special Needs Home of Tomorrow - Renowned Autism Consultant Valerie Herskowitz to Present Latest Findings at 'Autism Through the Lifespan' Conference February 14-17 in Orlando 2Health News:Healthy Coffee International, Inc. Establishes Healthy Coffee USA, Inc. as Its Marketing Arm 2Health News:The Best Way to Stoke Your Valentine's Fire: Don't Light Up 2
Aaron burr 4 handle for corneal rust ring removal...
Aaron Burr II with disposable 1mm burr for corneal rust ring removal and a diamond burr tip for polishing the pterygium bed after surgical removal and for lid margin lesions....
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings....
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings....
Medicine Products: